about
Are human endogenous retroviruses triggers of autoimmune diseases? Unveiling associations of three diseases and viral lociEstablishment of age- and sex-adjusted reference data for hand bone mass and investigation of hand bone loss in patients with rheumatoid arthritis treated in clinical practice: an observational study from the DANBIO registry and the Copenhagen OsteoIncreased galectin-3 may serve as a serologic signature of pre-rheumatoid arthritis while markers of synovitis and cartilage do not differ between early undifferentiated arthritis subsets.Risk of lymphoma and solid cancer among patients with rheumatoid arthritis in a primary care setting.Circulating surfactant protein -D is low and correlates negatively with systemic inflammation in early, untreated rheumatoid arthritis.Feasibility of a standardized ultrasound examination in patients with rheumatoid arthritis: a quality improvement among rheumatologists cohortA non-synonymous single-nucleotide polymorphism in the gene encoding Toll-like Receptor 3 (TLR3) is associated with sero-negative rheumatoid arthritis (RA) in a Danish population.Low-cost, low-field dedicated extremity magnetic resonance imaging in early rheumatoid arthritis: a 1-year follow-up studyImpact of Urate Level on Cardiovascular Risk in Allopurinol Treated Patients. A Nested Case-Control StudyDo rheumatoid arthritis patients in clinical practice benefit from switching from infliximab to a second tumor necrosis factor alpha inhibitor?The role of ultrasound in diagnosing rheumatoid arthritis, what do we know? An updated review.Physical Characteristics of a Citrullinated Pro-Filaggrin Epitope Recognized by Anti-Citrullinated Protein Antibodies in Rheumatoid Arthritis Sera.Is urate crystal precipitation a predictor of cardiovascular risk in hyperuricemic patients? A Danish cohort study.Factors associated with influenza and pneumococcal vaccine uptake among rheumatoid arthritis patients in Denmark invited to participate in a pneumococcal vaccine trial (Immunovax_RA).Prediction of treatment response to adalimumab: a double-blind placebo-controlled study of circulating microRNA in patients with early rheumatoid arthritis.Hand bone loss in early rheumatoid arthritis during a methotrexate-based treat-to-target strategy with or without adalimumab-a substudy of the optimized treatment algorithm in early RA (OPERA) trial.Bone edema on magnetic resonance imaging is an independent predictor of rheumatoid arthritis development in patients with early undifferentiated arthritis.Application of synthetic peptides for detection of anti-citrullinated peptide antibodies.A nationwide non-medical switch from originator infliximab to biosimilar CT-P13 in 802 patients with inflammatory arthritis: 1-year clinical outcomes from the DANBIO registry.Effect of a treat-to-target strategy based on methotrexate and intra-articular betamethasone with or without additional cyclosporin on MRI-assessed synovitis, osteitis, tenosynovitis, bone erosion, and joint space narrowing in early rheumatoid arthrEffectiveness and drug adherence of biologic monotherapy in routine care of patients with rheumatoid arthritis: a cohort study of patients registered in the Danish biologics registry.Effect of Allopurinol on Cardiovascular Outcomes in Hyperuricemic Patients: A Cohort Study.Antibodies to infliximab and adalimumab in patients with rheumatoid arthritis in clinical remission: a cross-sectional study.Interactions between smoking, increased serum levels of anti-CCP antibodies, rheumatoid factors, and erosive joint disease in patients with early, untreated rheumatoid arthritis.Interleukin-6-receptor polymorphisms rs12083537, rs2228145, and rs4329505 as predictors of response to tocilizumab in rheumatoid arthritis.Impact of different infliximab dose regimens on treatment response and drug survival in 462 patients with psoriatic arthritis: results from the nationwide registries DANBIO and ICEBIO.Radiographic progression and remission rates in early rheumatoid arthritis - MRI bone oedema and anti-CCP predicted radiographic progression in the 5-year extension of the double-blind randomised CIMESTRA trial.Direct comparison of treatment responses, remission rates, and drug adherence in patients with rheumatoid arthritis treated with adalimumab, etanercept, or infliximab: results from eight years of surveillance of clinical practice in the nationwide DAdalimumab added to a treat-to-target strategy with methotrexate and intra-articular triamcinolone in early rheumatoid arthritis increased remission rates, function and quality of life. The OPERA Study: an investigator-initiated, randomised, double-Eosinophilia in routine blood samples and the subsequent risk of hematological malignancies and death.Which factors influence radiographic progression during treatment with tumor necrosis factor inhibitors in clinical practice? Results from 930 patients with rheumatoid arthritis in the nationwide Danish DANBIO registry.Clinical response, drug survival and predictors thereof in 432 ankylosing spondylitis patients after switching tumour necrosis factor α inhibitor therapy: results from the Danish nationwide DANBIO registry.[Carotinaemia in patient with excessive beta-carotene food-intake and dysregulated diabetes mellitus].Upregulated baseline plasma CCL19 and CCR7 cell-surface expression on monocytes in early rheumatoid arthritis normalized during treatment and CCL19 correlated with radiographic progression.Circulating surfactant protein D is decreased in early rheumatoid arthritis: a 1-year prospective study.Clinical response, drug survival, and predictors thereof among 548 patients with psoriatic arthritis who switched tumor necrosis factor α inhibitor therapy: results from the Danish Nationwide DANBIO Registry.Differential association of the N-propeptide of collagen IIA (PIIANP) and collagen II C-telopeptide (CTX-II) with synovitis and erosions in early and longstanding rheumatoid arthritis.Impact of tumour necrosis factor inhibitor treatment on radiographic progression in rheumatoid arthritis patients in clinical practice: results from the nationwide Danish DANBIO registry.Do changes in prescription practice in patients with rheumatoid arthritis treated with biological agents affect treatment response and adherence to therapy? Results from the nationwide Danish DANBIO Registry.Clinical and radiographic outcome of a treat-to-target strategy using methotrexate and intra-articular glucocorticoids with or without adalimumab induction: a 2-year investigator-initiated, double-blinded, randomised, controlled trial (OPERA).
P50
Q28601992-E2E408A7-AE9A-49B3-9FE5-222F586469A0Q28603734-258018FC-13DF-4A35-8F3D-C1BF5AC71464Q33608900-F8720571-CA19-467A-B22D-8EFFD0FDBE86Q33734256-743CFBF2-807E-40FF-A5BB-B715B19CD22CQ33923272-5865E15C-6E72-4FA4-9DDC-DC4AD5A5CE37Q34192012-8EF6C4A0-2674-4452-A3C4-652E0688DE5BQ34346248-D4A0CBCD-8CB5-477C-8845-E4F672A75CEBQ35637890-4CBD53E0-A505-4E71-A517-BD137FE1FCF5Q35889954-8569216A-74F0-4C05-880B-048656C74941Q35954640-1CF97829-A492-4A26-AE23-5628B88A1535Q36179836-118415A5-72F4-480A-911E-15A542C20031Q36230539-2C22AA96-F080-4E07-B2F3-C24D8C987048Q36233048-D89662C5-3F25-4927-9FFD-7C213786974AQ38987500-FB0CC95B-34F0-4B65-922F-57334966777BQ39011089-B1041A8A-66FE-4F72-AC07-10773049392EQ39127801-3B27DDA7-CA98-43F1-99DB-D6800CD26DACQ39761544-D29A24D3-E197-4975-BA35-6DF42F9666B7Q40076861-DE3AC6EA-E6B1-4112-8914-C6851716BD85Q40214597-BBDCA8B3-2502-4177-AC19-0217827DF7EDQ40495043-22A57E39-DFA6-4798-BB6B-87F457CCF8CCQ40735887-D928828A-7F3C-42F6-950C-A7B51C366EF0Q41109374-C331D6A5-61B9-4D47-9E21-FA8FA0DAB44DQ41248107-86305774-1FA6-4C15-89D1-20BF2725FB49Q41745650-5157151A-F3CB-48AC-B8AC-8AE5F8483849Q42208275-ABB2C139-43B2-402F-92DF-3CBF356FCEBFQ42210089-3D5522C4-C18B-4F1F-9B2E-3A67E3E02FDFQ43073143-9F79AD50-47D0-4695-84AD-1DD3A1E4A885Q43205844-975E9247-E057-4FE0-8CA5-CF41FD266EABQ43607385-5401A997-C66E-4DB5-90AD-77466581931AQ44007100-F4327EA8-368F-408E-8105-91E1FCEFA5B9Q44565064-DFAE105B-8441-451C-98CA-2AB508BCA577Q45229094-3531069C-2D75-4393-8D47-7695C652DCFBQ46142594-428CCA84-39A3-4392-A889-BA5107E2430EQ46274578-BAA3FF1E-4776-4B99-917D-0BD49953F546Q46871317-656039D2-E02E-45FD-A1BE-734025ADD460Q46893265-ABEC0827-3A60-4DE6-BD02-6FF48C8A11D6Q47715952-742FCE2D-1C1F-42BF-8082-F1A00617D79FQ47855052-2941F1CE-BBE4-4CFC-9A02-1C3AE4459D1EQ50546839-410BA3C7-E93B-4A57-910F-D101FA3727AEQ50921450-5F4C51F2-90B0-49DB-9B31-F0EA20217D7D
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Hanne Lindegaard
@ast
Hanne Lindegaard
@en
Hanne Lindegaard
@es
Hanne Lindegaard
@nl
Hanne Lindegaard
@sl
type
label
Hanne Lindegaard
@ast
Hanne Lindegaard
@en
Hanne Lindegaard
@es
Hanne Lindegaard
@nl
Hanne Lindegaard
@sl
prefLabel
Hanne Lindegaard
@ast
Hanne Lindegaard
@en
Hanne Lindegaard
@es
Hanne Lindegaard
@nl
Hanne Lindegaard
@sl
P106
P21
P31
P496
0000-0002-5675-3859